- Home
- NMRA vs PDYN Comparison
NMRA vs PDYN Comparison
Compare NMRA & PDYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- PDYN
- Stock Information
- Founded
- NMRA 2019
- PDYN 1983
- Country
- NMRA United States
- PDYN United States
- Employees
- NMRA N/A
- PDYN N/A
- Industry
- NMRA
- PDYN Wholesale Distributors
- Sector
- NMRA
- PDYN Industrials
- Exchange
- NMRA Nasdaq
- PDYN Nasdaq
- Market Cap
- NMRA 268.5M
- PDYN 271.4M
- IPO Year
- NMRA 2023
- PDYN N/A
- Fundamental
- Price
- NMRA $1.57
- PDYN $7.71
- Analyst Decision
- NMRA Hold
- PDYN Hold
- Analyst Count
- NMRA 8
- PDYN 1
- Target Price
- NMRA $5.83
- PDYN $8.00
- AVG Volume (30 Days)
- NMRA 376.3K
- PDYN 1.5M
- Earning Date
- NMRA 11-11-2025
- PDYN 11-12-2025
- Dividend Yield
- NMRA N/A
- PDYN N/A
- EPS Growth
- NMRA N/A
- PDYN N/A
- EPS
- NMRA N/A
- PDYN N/A
- Revenue
- NMRA N/A
- PDYN $4,357,000.00
- Revenue This Year
- NMRA N/A
- PDYN N/A
- Revenue Next Year
- NMRA N/A
- PDYN $97.52
- P/E Ratio
- NMRA N/A
- PDYN N/A
- Revenue Growth
- NMRA N/A
- PDYN N/A
- 52 Week Low
- NMRA $0.61
- PDYN $1.61
- 52 Week High
- NMRA $17.19
- PDYN $14.95
- Technical
- Relative Strength Index (RSI)
- NMRA 46.94
- PDYN 53.73
- Support Level
- NMRA $1.42
- PDYN $7.01
- Resistance Level
- NMRA $1.59
- PDYN $7.50
- Average True Range (ATR)
- NMRA 0.10
- PDYN 0.40
- MACD
- NMRA -0.03
- PDYN 0.10
- Stochastic Oscillator
- NMRA 36.14
- PDYN 91.34
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About PDYN Palladyne AI Corp.
Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.